This is excellent work by METAvivor, the sole US organization dedicated to awarding funding for stage IV breast cancer research. This October let’s take action. Let’s help fund research for the 30% of women who develop metastatic breast cancer. Did you know that metastatic disease only receives 2% of breast cancer research funding? That’s not a typo. 2%. Or, did you know that outcomes haven’t changed for metastatic patients in 10 years? Please, watch this video, all the way to the end, and if you want to make a difference this October, don’t just shop pink. Give money to organizations like METAvivor, that directly fund research for patients.
Something must be in the water. First, in January, there was the absurd cancer patient shaming that the awful Keller duo vomited on the public. Now, we have Kohl's and Susan G. Komen undermining the work of METAvivor, the only organization in the U.S. dedicated to awarding research funding for Stage IV breast cancer. METAvivor … Continue reading Drowning in Pink
Currently, I work for Myriad Genetic Laboratories, and if you haven't heard of Myriad this summer, I would be surprised. This past June, the Supreme Court ruled that five of Myriad's claims covering isolated DNA were not patent eligible. Regardless of the decision, Myriad has more than 500 valid and enforceable claims in 24 different … Continue reading Committed.